Trametinib price introduction

Trametinib(Trametinib) is an oral tablet developed by GlaxoSmithKline (GSK). It was approved by the U.S. Food and Drug Administration (FDA) on May 29, 2013, and is marketed in the United States under the trade name Mekinist. This drug is mainly used to treat unresectable or metastatic melanoma associated with BRAF (murine sarcoma oncogenic homolog B1 gene) V600E or V600K mutations. However, it should be noted that trametinib is not recommended for patients who have already received BRAF inhibitor treatment.

The main mechanism of action of trametinib is to affect the proliferation of cancer cells by inhibiting MEK 1 / 2 (a dual-specificity protein kinase) in the mitogen-activated protein kinase (MAPK) pathway. Preclinical data show that BRAF-altered cells are particularly sensitive to MEK inhibitors, so trametinib can significantly reduce ERK phosphorylation, thereby inhibiting the growth and spread of tumor cells.

However, the use of trametinib may also cause some side effects, such as weakness, fatigue, vomiting, stomach discomfort, etc. In severe cases, signs of allergic reactions, blood clots, bleeding, etc. may occur. Therefore, it needs to be used under the guidance of a doctor, and regular examinations are required to observe the condition and drug reaction.

In general, trametinib is an effective treatment drug for melanoma with specific gene mutations, but it must be used strictly in accordance with medical instructions and pay attention to the drug response.

Nowadays, trametinib has been included in my country's medical insurance directory. The trametinib available in the domestic market is an original drug, and each box contains2mg*30 tablets. After medical insurance reimbursement, the price per box is less than 12,000 yuan. As far as we know, generic versions of trametinib have been launched overseas, many of which are produced and sold by multiple pharmaceutical factories in Laos. They are also in the specification of 2 mg and 30 tablets, but the price is only about 1,900 yuan. Feedback from patients using the generic version of trametinib is quite good, and everyone can choose the appropriate drug according to their actual needs. If you have any questions about trametinib, it is recommended to consult a professional overseas medical consultant.